谷歌浏览器插件
订阅小程序
在清言上使用

Supplementary Figure S1 from Safety and Efficacy of Axicabtagene Ciloleucel Versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

crossref(2023)

引用 0|浏览0
暂无评分
摘要
Event-free survival per central review and objective response rate in patients ≥70 years
更多
查看译文
关键词
Mantle Cell Lymphoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要